13F-HR 1 w60775e13f-hr.txt FORM 13F UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: March 31, 2002 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Schaffhausen Switzerland CH-8200 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: R. Di Girolamo Title: SIGNING AUTHORITY ---------------- Phone: (41-41) 724-5959 Signature, Place, and Date of Signing: /s/ R. Di Girolamo ----------------------------------- Zug, Switzerland, May 15, 2002 Report Type (Check only one.): [ ] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [X] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Name Biotech Focus N.V. Biotech Invest N.V. Biotech Target N.V. Biotech Growth N.V. Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 4 Form 13F Information Table Entry Total: 22 Form 13F Information Table Value Total: $1,555,587 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Name 1 Biotech Focus N.V. 2 Biotech Invest N.V. 3 Biotech Target N.V. 4 Biotech Growth N.V. BB BIOTECH AG FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 -------- -------- -------- -------- -------- -------- -------- -------- TITLE OF VALUE SHS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE -------------- ----- ----- -------- ------- --- ---- ---------- -------- ---- ------ ---- Adolor Corp. COM 00724X102 19,429 1,742,500 SH DEFINED 3 1,742,500 NONE NONE Amgen Inc. COM 00075886F1 338,684 5,675,000 SH DEFINED 1 5,675,000 NONE NONE CV Therapeutics, Inc. COM 12666710 62,016 1,713,147 SH DEFINED 3 1,713,147 NONE NONE Cell Therapeutics, Inc. COM 150934107 22,856 920,500 SH DEFINED 3 920,500 NONE NONE Cephalon Inc. COM 156708109 31,500 500,000 SH DEFINED 1 500,000 NONE NONE Cubist Pharmaceuticals, Inc. COM 229678107 20,698 1,120,000 SH DEFINED 3 1,120,000 NONE NONE Durect Corporation COM 266605104 17,566 2,254,957 SH DEFINED 4 2,254,957 NONE NONE Endo Pharmaceuticals COM 29264P104 10,979 1,087,000 SH DEFINED 3 1,087,000 NONE NONE GenVec COM 37246C109 2,743 911,185 SH DEFINED 4 911,185 NONE NONE IDEC Pharmaceuticals COM 449370105 301,053 4,682,000 SH DEFINED 1 4,682,000 NONE NONE ImClone Systems COM 45245W109 74,244 3,014,361 SH DEFINED 2 3,014,361 NONE NONE Medicines Company (The) COM 584688105 74,221 5,204,837 SH DEFINED 4 5,204,837 NONE NONE MedImmune COM 584699102 441,235 11,218,784 SH DEFINED 1 11,218,784 NONE NONE Neurocrine Biosciences COM 64125C109 63,199 1,557,000 SH DEFINED 3 1,557,000 NONE NONE Pozen, Inc. COM 73941U102 3,032 524,500 SH DEFINED 3 524,500 NONE NONE Regeneron Pharmaceuticals, Inc. COM 75886F107 5,998 240,000 SH DEFINED 3 240,000 NONE NONE Serono SA ADR 81752M101 10,102 451,000 SH DEFINED 1 451,000 NONE NONE Third Wave Technologies COM 88428W108 3,932 1,173,800 SH DEFINED 4 1,173,800 NONE NONE 3-Dimensional Pharmaceuticals, Inc. COM 88554W104 19,469 2,850,483 SH DEFINED 4 2,850,483 NONE NONE Titan Pharmaceuticals, Inc. COM 888314101 3,466 494,500 SH DEFINED 3 494,500 NONE NONE Transkaryotic Therapies COM 89373510 20,729 481,500 SH DEFINED 2 481,500 NONE NONE Virologic COM 92823R201 8,436 3,605,004 SH DEFINED 4 3,605,004 NONE NONE